Myelodysplastic Syndromes Foundation

Analysis

Myelodysplastic Syndromes Foundation is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in April 2000, 26 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Myelodysplastic Syndromes Foundation reported income of $2.7m and spending of $3.1m, spending 114% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $2.9m to $2.7m (-5.5%), an average of -1.4% a year. The sharpest change came in the year to December 2022, when income dropped by 46%. Over the whole period it spent 78% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Myelodysplastic Syndromes Foundation sits at the 74th percentile: it is larger than about 74% of them. Against every charity in United States with reported income it ranks in the 88th percentile, and in the 85th percentile within NY. Charities of a similar size with the same main cause include Kuakini Support Services Inc ($2.7m), Rio Grande Alcoholism Treatment Center Incorporated ($2.7m) and North Hill Home Health Care Inc ($2.7m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 57% and program service revenue 35% of the total. Compensation of current officers, directors and key employees was $147k (4.7% of expenses). Other salaries and wages came to $419k. At year end it held assets of $5.2m against liabilities of $470k, net assets of $4.7m. It reported 9 employees.